Company decision to pull diabetes drug could add 9 million to NHS drugs bill

Wednesday, August 4, 2010 - 04:56 in Health & Medicine

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add GBP9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB)...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net